Global Information
회사소개 | 문의 | 비교리스트

메타볼로믹스 시장 : 세계 산업 동향, 점유율, 규모, 성장률, 기회, 예측(2020-2025년)

Metabolomics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025

리서치사 IMARC Services Private Limited
발행일 2020년 06월 상품 코드 945312
페이지 정보 영문 110 Pages
가격
US $ 2,299 ₩ 2,715,000 PDF (Single User License)
US $ 3,399 ₩ 4,015,000 PDF (5 User License)
US $ 4,499 ₩ 5,314,000 PDF (Corporate License)


메타볼로믹스 시장 : 세계 산업 동향, 점유율, 규모, 성장률, 기회, 예측(2020-2025년) Metabolomics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025
발행일 : 2020년 06월 페이지 정보 : 영문 110 Pages

세계의 메타볼로믹스 시장은 강력한 성장을 보이고 있으며, 예측 기간 중 약 13%의 CAGR로 성장할 것으로 예측되고 있습니다. 암 및 기타 만성질환의 유병률 증가, 의약품 산업의 성장, 맞춤형 의료의 수요 증가 등의 요인이 이 시장의 성장을 촉진하고 있습니다. 또한 메타볼로믹스와 기계학습(ML)의 통합도 시장의 성장에 유리하게 작용하고 있습니다. ML은 NMR 및 MS 기술로 생성된 데이터의 정확한 해석을 지원하며, 복잡하고 반복적이며 시간이 걸리는 프로세스를 자동화합니다. 급속한 도시화 및 바이오테크놀러지 분야에서 대규모 R&D 등의 요인도 향후 시장 성장을 촉진할 것으로 예측됩니다.

세계의 메타볼로믹스 시장을 조사했으며, 시장 및 기술의 개요, 시장 성장에 대한 각종 영향요인 분석, 시장 규모의 추이·예측, 제품·적응증·용도·지역/주요 국가 등 각종 부문별 내역, 경쟁 환경, 주요 기업 개요 등을 정리하여 전해드립니다.

제1장 서문

제2장 조사 범위·조사 방법

제3장 개요

제4장 서론

제5장 세계의 메타볼로믹스 시장

  • 시장 개요
  • 시장 실적

제6장 시장 분석·예측 : 제품별

  • 기기
  • 바이오인포매틱스 툴·서비스

제7장 시장 분석·예측 : 적응증별

  • 심혈관질환
  • 신경질환
  • 선천성 대사이상
  • 기타

제8장 시장 분석·예측 : 용도별

  • 바이오마커·Drug Discovery
  • 독물학
  • 영양유전체학
  • 맞춤형 의료
  • 기타

제9장 시장 분석·예측 : 지역·주요 국가별

  • 북미
    • 미국
    • 캐나다
  • 아시아태평양
    • 중국
    • 일본
    • 인도
    • 한국
    • 호주
    • 인도네시아
    • 기타
  • 유럽
    • 독일
    • 프랑스
    • 영국
    • 이탈리아
    • 스페인
    • 러시아
    • 기타
  • 라틴아메리카
    • 브라질
    • 멕시코
    • 기타
  • 중동·아프리카

제10장 SWOT 분석

제11장 밸류체인 분석

제12장 Porter의 산업 분석

제13장 경쟁 구도

  • 시장 구조
  • 주요 기업
  • 주요 기업의 개요
    • Agilent Technologies Inc.
    • Biocrates Life Sciences AG
    • Bio-Rad Laboratories Inc.
    • Bruker Corporation
    • Danaher Corporation
    • Human Metabolome Technologies Inc.
    • Metabolon Inc.
    • Shimadzu Corporation
    • Thermo Fisher Scientific Inc.
    • Waters Corporation
KSA 20.07.13

List of Figures

  • Figure 1: Global: Metabolomics Market: Major Drivers and Challenges
  • Figure 2: Global: Metabolomics Market: Sales Value (in Billion US$), 2014-2019
  • Figure 3: Global: Metabolomics Market: Breakup by Product (in %), 2019
  • Figure 4: Global: Metabolomics Market: Breakup by Indication (in %), 2019
  • Figure 5: Global: Metabolomics Market: Breakup by Application (in %), 2019
  • Figure 6: Global: Metabolomics Market: Breakup by Region (in %), 2019
  • Figure 7: Global: Metabolomics Market Forecast: Sales Value (in Billion US$), 2020-2025
  • Figure 8: Global: Metabolomics (Metabolomics Instruments) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 9: Global: Metabolomics (Metabolomics Instruments) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 10: Global: Metabolomics (Metabolomics Bioinformatics Tools and Services) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 11: Global: Metabolomics (Metabolomics Bioinformatics Tools and Services) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 12: Global: Metabolomics (Cancer) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 13: Global: Metabolomics (Cancer) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 14: Global: Metabolomics (Cardiovascular Disorders) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 15: Global: Metabolomics (Cardiovascular Disorders) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 16: Global: Metabolomics (Neurological Disorders) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 17: Global: Metabolomics (Neurological Disorders) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 18: Global: Metabolomics (Inborn Errors of Metabolism) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 19: Global: Metabolomics (Inborn Errors of Metabolism) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 20: Global: Metabolomics (Other Indications) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 21: Global: Metabolomics (Other Indications) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 22: Global: Metabolomics (Biomarker and Drug Discovery) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 23: Global: Metabolomics (Biomarker and Drug Discovery) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 24: Global: Metabolomics (Toxicology) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 25: Global: Metabolomics (Toxicology) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 26: Global: Metabolomics (Nutrigenomics) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 27: Global: Metabolomics (Nutrigenomics) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 28: Global: Metabolomics (Personalized Medicine) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 29: Global: Metabolomics (Personalized Medicine) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 30: Global: Metabolomics (Other Applications) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 31: Global: Metabolomics (Other Applications) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 32: North America: Metabolomics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 33: North America: Metabolomics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 34: United States: Metabolomics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 35: United States: Metabolomics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 36: Canada: Metabolomics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 37: Canada: Metabolomics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 38: Asia Pacific: Metabolomics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 39: Asia Pacific: Metabolomics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 40: China: Metabolomics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 41: China: Metabolomics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 42: Japan: Metabolomics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 43: Japan: Metabolomics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 44: India: Metabolomics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 45: India: Metabolomics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 46: South Korea: Metabolomics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 47: South Korea: Metabolomics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 48: Australia: Metabolomics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 49: Australia: Metabolomics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 50: Indonesia: Metabolomics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 51: Indonesia: Metabolomics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 52: Others: Metabolomics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 53: Others: Metabolomics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 54: Europe: Metabolomics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 55: Europe: Metabolomics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 56: Germany: Metabolomics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 57: Germany: Metabolomics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 58: France: Metabolomics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 59: France: Metabolomics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 60: United Kingdom: Metabolomics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 61: United Kingdom: Metabolomics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 62: Italy: Metabolomics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 63: Italy: Metabolomics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 64: Spain: Metabolomics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 65: Spain: Metabolomics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 66: Russia: Metabolomics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 67: Russia: Metabolomics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 68: Others: Metabolomics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 69: Others: Metabolomics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 70: Latin America: Metabolomics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 71: Latin America: Metabolomics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 72: Brazil: Metabolomics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 73: Brazil: Metabolomics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 74: Mexico: Metabolomics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 75: Mexico: Metabolomics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 76: Argentina: Metabolomics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 77: Argentina: Metabolomics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 78: Columbia: Metabolomics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 79: Columbia: Metabolomics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 80: Chile: Metabolomics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 81: Chile: Metabolomics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 82: Peru: Metabolomics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 83: Peru: Metabolomics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 84: Others: Metabolomics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 85: Others: Metabolomics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 86: Middle East and Africa: Metabolomics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 87: Middle East and Africa: Metabolomics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 88: Global: Metabolomics Industry: SWOT Analysis
  • Figure 89: Global: Metabolomics Industry: Value Chain Analysis
  • Figure 90: Global: Metabolomics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Metabolomics Market: Key Industry Highlights, 2019 and 2025
  • Table 2: Global: Metabolomics Market Forecast: Breakup by Product (in Million US$), 2020-2025
  • Table 3: Global: Metabolomics Market Forecast: Breakup by Indication (in Million US$), 2020-2025
  • Table 4: Global: Metabolomics Market Forecast: Breakup by Application (in Million US$), 2020-2025
  • Table 5: Global: Metabolomics Market Forecast: Breakup by Region (in Million US$), 2020-2025
  • Table 6: Global: Metabolomics Market: Competitive Structure
  • Table 7: Global: Metabolomics Market: Key Players

The global metabolomics market is currently witnessing strong growth. Metabolomics refers to the large-scale study of metabolites, or small molecules, in cells, biofluids, tissues and organisms. It is an analytical approach for systematic metabolic profiling and fingerprinting in various biological samples and systems. It consists of various detection techniques, such as nuclear magnetic resonance (NMR) spectroscopy and mass spectrometry (MS), along with separation techniques, such as gas chromatography. These techniques are commonly used for metabolome studies, toxicology testing and developing personalized medicine. They also provide an assessment of health and an insight into the causes and treatment of medical ailments, such as cardiovascular and neurological diseases and cancer.

The increasing prevalence of cancer and other chronic diseases is one of the key factors driving the growth of the market. Furthermore, a significant increase in the pharmaceutical industry, along with the rising demand for personalized medicines, is also providing a boost to the market growth. Metabolomics facilitates the study of genes and proteins, along with the development of biomarkers that aid in the discovery and development of medicines and managing disease progression. Additionally, the integration of metabolomics with machine learning (ML) is also favoring the market growth. ML aids in the accurate interpretation of data generated using the NMR and MS techniques and automates complex, repetitive and time-consuming processes. Advanced ML software also offers comprehensive analysis and visualization functions for the representation of large amounts of data. Other factors, including rapid urbanization and extensive research and development (R&D) activities in the field of biotechnology, are projected to drive the market in the upcoming years. Looking forward, IMARC Group expects the market to grow at a CAGR of around 13% during 2020-2025.

Breakup by Product:

  • Metabolomics Instruments
  • Metabolomics Bioinformatics Tools and Services

Breakup by Indication:

  • Cancer
  • Cardiovascular Disorders
  • Neurological Disorders
  • Inborn Errors of Metabolism
  • Others

Breakup by Application:

  • Biomarker and Drug Discovery
  • Toxicology
  • Nutrigenomics
  • Personalized Medicine
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

  • The competitive landscape of the industry has also been examined with some of the key players being Agilent Technologies Inc., Biocrates Life Sciences AG, Bio-Rad Laboratories Inc., Bruker Corporation, Danaher Corporation, Human Metabolome Technologies Inc., Metabolon Inc., Shimadzu Corporation, Thermo Fisher Scientific Inc., Waters Corporation, etc.

Key Questions Answered in This Report:

  • How has the global metabolomics market performed so far and how will it perform in the coming years?
  • What are the key regional markets?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the indication?
  • What is the breakup of the market based on the application?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global metabolomics market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Metabolomics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Market Forecast

6 Market Breakup by Product

  • 6.1 Metabolomics Instruments
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Metabolomics Bioinformatics Tools and Services
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Indication

  • 7.1 Cancer
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Cardiovascular Disorders
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Neurological Disorders
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Inborn Errors of Metabolism
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Biomarker and Drug Discovery
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Toxicology
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Nutrigenomics
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Personalized Medicine
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 Agilent Technologies Inc.
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 Biocrates Life Sciences AG
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
    • 13.3.3 Bio-Rad Laboratories Inc.
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
      • 13.3.3.3 Financials
      • 13.3.3.4 SWOT Analysis
    • 13.3.4 Bruker Corporation
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
      • 13.3.4.3 Financials
    • 13.3.5 Danaher Corporation
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
      • 13.3.5.3 Financials
      • 13.3.5.4 SWOT Analysis
    • 13.3.6 Human Metabolome Technologies Inc.
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
      • 13.3.6.3 Financials
    • 13.3.7 Metabolon Inc.
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
    • 13.3.8 Shimadzu Corporation
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
      • 13.3.8.3 Financials
      • 13.3.8.4 SWOT Analysis
    • 13.3.9 Thermo Fisher Scientific Inc.
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
      • 13.3.9.3 Financials
      • 13.3.9.4 SWOT Analysis
    • 13.3.10 Waters Corporation
      • 13.3.10.1 Company Overview
      • 13.3.10.2 Product Portfolio
      • 13.3.10.3 Financials
      • 13.3.10.4 SWOT Analysis
Back to Top
전화 문의
F A Q